Trolamine salicylate 100 MG/ML Topical Cream — RxCUI 313518
RxNorm drug concept · Semantic clinical drug
RxCUI 313518
Semantic clinical drug · SCD
● Current RxNorm concept 16 FDA products
18 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI313518
Official nameTrolamine salicylate 100 MG/ML Topical Cream
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known astrolamine salicylate 10 % Topical Cream
FDA products mapped16
Package NDCs mapped18
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How Trolamine salicylate 100 MG/ML Topical Cream Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Trolamine salicylate 100 MG/ML Topical Cream
RxCUI 313518 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Trolamine salicylate
38866IN
-
Trolamine salicylate
-
Brand names 4
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Aspercreme
215427BN -
Mobisyl
1101833BN -
Myoflex
224897BN -
Sportscreme
220006BN
-
Aspercreme
-
Dose forms 12
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Trolamine salicylate Topical Cream
379059SCDF -
Trolamine salicylate Topical Product
1163392SCDG -
Trolamine salicylate Topical Cream [Aspercreme]
1101826SBDF -
Trolamine salicylate Topical Cream [Mobisyl]
1101835SBDF -
Trolamine salicylate Topical Cream [Myoflex]
1091464SBDF -
Trolamine salicylate Topical Cream [Sportscreme]
1101842SBDF -
Aspercreme Topical Product
1172156SBDG -
Mobisyl Topical Product
1181074SBDG - +4 more in this family
-
Trolamine salicylate Topical Cream
-
Clinical & branded drugs 9
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Trolamine salicylate 100 MG/ML
358438SCDC -
Trolamine salicylate 100 MG/ML Topical Cream [Aspercreme]
1101827SBD -
Trolamine salicylate 100 MG/ML Topical Cream [Mobisyl]
1101836SBD -
Trolamine salicylate 100 MG/ML Topical Cream [Myoflex]
1091465SBD -
Trolamine salicylate 100 MG/ML Topical Cream [Sportscreme]
1101843SBD -
Trolamine salicylate 100 MG/ML [Aspercreme]
1101825SBDC -
Trolamine salicylate 100 MG/ML [Mobisyl]
1101834SBDC -
Trolamine salicylate 100 MG/ML [Myoflex]
1091463SBDC - +1 more in this family
-
Trolamine salicylate 100 MG/ML
Showing up to 8 concepts per family — 21 of 26 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Trolamine salicylate 100 MG/ML
SCDC · 358438 -
Trolamine salicylate Topical Cream
SCDF · 379059 -
Trolamine salicylate Topical Product
SCDG · 1163392
Brand-Name Concepts
-
Trolamine salicylate 100 MG/ML Topical Cream [Aspercreme]
SBD · 1101827 -
Trolamine salicylate 100 MG/ML Topical Cream [Mobisyl]
SBD · 1101836 -
Trolamine salicylate 100 MG/ML Topical Cream [Myoflex]
SBD · 1091465 -
Trolamine salicylate 100 MG/ML Topical Cream [Sportscreme]
SBD · 1101843 -
Trolamine salicylate 100 MG/ML [Aspercreme]
SBDC · 1101825 -
Trolamine salicylate 100 MG/ML [Mobisyl]
SBDC · 1101834 -
Trolamine salicylate 100 MG/ML [Myoflex]
SBDC · 1091463 -
Trolamine salicylate 100 MG/ML [Sportscreme]
SBDC · 1101841 -
Trolamine salicylate Topical Cream [Aspercreme]
SBDF · 1101826 -
Trolamine salicylate Topical Cream [Mobisyl]
SBDF · 1101835
📦 FDA Products & Package NDCs
16 products · 18 package NDCs
18 package NDCs map to RxCUI 313518 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00225-0360-11 | 100 g in 1 TUBE (0225-0360-11) | MOBISYL | BF ASCHER AND CO INC | 2014-09-19 |
| 00225-0360-35 | 226.8 g in 1 JAR (0225-0360-35) | MOBISYL | BF ASCHER AND CO INC | 2014-09-19 |
| 00363-3630-01 | 1 TUBE in 1 CARTON (0363-3630-01) / 113 g in 1 TUBE | Walgreens Pain Relieving Plus Turmeric Analgesic | Walgreen Company | 2021-06-22 |
| 41167-0570-03 | 1 TUBE in 1 CARTON (41167-0570-3) / 85 g in 1 TUBE | Aspercreme Pain Relieving | Chattem, Inc. | 1998-12-01 |
| 41167-0570-05 | 1 TUBE in 1 CARTON (41167-0570-5) / 142 g in 1 TUBE | Aspercreme Pain Relieving | Chattem, Inc. | 1998-12-01 |
| 41250-0418-01 | 1 TUBE in 1 CARTON (41250-418-01) / 85 g in 1 TUBE | Meijer Analgesic with Aloe Topical Analgesic | Meijer Distribution, Inc | 2019-04-01 |
| 50804-0207-03 | 1 TUBE in 1 CARTON (50804-207-03) / 85 g in 1 TUBE | Arthritis Relief GoodSense | Geiss, Destin & Dunn, Inc | 2019-11-01 |
| 51316-0990-10 | 85 g in 1 TUBE (51316-990-10) | Arthritis Cream | CVS | 2022-09-15 |
| 57237-0355-85 | 1 TUBE in 1 CARTON (57237-355-85) / 85 g in 1 TUBE | Jointiva | Rising Pharma Holdings, Inc. | 2025-12-16 |
| 62742-4091-01 | 57 g in 1 TUBE (62742-4091-1) | Pain Relief Cream | ALLURE LABS INC. | 2017-11-27 |
| 69993-0300-03 | 88 g in 1 TUBE (69993-300-03) | Blue-Emu Maximum Pain Relief | Kingsway Pharmaceuticals dba NFI, LLC | 2020-08-01 |
| 70000-0744-01 | 1 TUBE in 1 CARTON (70000-0744-1) / 85 g in 1 TUBE | Pain Relieving | CARDINAL HEALTH 110, LLC. DBA LEADER | 2025-12-04 |
| 72562-0103-03 | 85 g in 1 TUBE (72562-103-03) | Tommie Copper Pain Relief Maximum Strength | Tommie Copper, Inc. | 2020-12-14 |
| 72562-0223-25 | 70 g in 1 TUBE (72562-223-25) | Tommie Copper Pain Relief | Tommie Copper, Inc. | 2021-08-19 |
| 72839-0213-03 | 1 TUBE in 1 CARTON (72839-213-03) / 85 g in 1 TUBE | Warrior Arthritis Relief | Derma Care Research Labs, LLC | 2023-04-21 |
| 72839-0214-03 | 1 TUBE in 1 CARTON (72839-214-03) / 85 g in 1 TUBE | DCH Arthritis Relief | Derma Care Research Labs, LLC | 2021-10-20 |
| 79903-0117-01 | 1 TUBE in 1 CARTON (79903-117-01) / 85 g in 1 TUBE | Equate Odor-Free Therapy Arthritis Analgesic | Wal-Mart Stores, Inc. | 2022-03-25 |
| 83520-0214-03 | 1 TUBE in 1 CARTON (83520-214-03) / 85 g in 1 TUBE | Dermachange Arthritis Relief | Private Beauty Label and Wellness | 2024-01-31 |
Observed labelers:
BF ASCHER AND CO INC (2) ·
Chattem, Inc. (2) ·
Derma Care Research Labs, LLC (2) ·
Tommie Copper, Inc. (2) ·
ALLURE LABS INC. (1) ·
CARDINAL HEALTH 110, LLC. DBA LEADER (1)
· +8 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.